Patents by Inventor Peter Keane

Peter Keane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11201789
    Abstract: An augmented connection graph can be created based on a task to be performed by a fog computing node by augmenting a connection graph representing plurality of IoT devices and connections among them. The augmenting can include adding to the connection graph data type nodes representing types of data processed by the fog computing node and adding connections between the data type nodes and IoT devices that generate the type of data represented by the respective data type nodes. A connection can be added between each pair of the IoT devices that are not currently connected and for which a level of correlation between the pair of IoT devices at least equals a threshold value. Based on the augmented connection graph, at least one of the IoT devices to assign to the fog computing node can be determined and assigned to the fog computing node.
    Type: Grant
    Filed: February 12, 2021
    Date of Patent: December 14, 2021
    Assignees: INTERNATIONAL BUSINESS MACHINES CORPORATION, NATIONAL UNIVERSITY OF IRELAND MAYNOOTH
    Inventors: Peter Keane, Faisal Ghaffar, David W. Malone
  • Patent number: 8583467
    Abstract: A computer-implemented method is provided for optimizing scheduling and resource allocation for a workflow. The method includes receiving i) resource information representing resources available for allocation to the workflow and ii) one or more workflow constraints. The method determines one or more probable sequences for executing the workflow. Each probable sequence includes tasks usable to execute at least a portion of the workflow. Each task is assigned a probability of task execution. The method assigns a probability of sequence execution to each of the probable sequences based on the probability of task execution of the tasks forming the probable sequence. The method further determines an optimized scenario for scheduling the workflow based on the probable sequences. The optimized scenario can have an optimized probability of completion.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: November 12, 2013
    Assignee: FMR LLC
    Inventors: Sean Morris, Peter Keane, Igor Nikolaev, Tom Mulligan
  • Patent number: 5468750
    Abstract: A compound of formula ##STR1## in which A represents S;R.sub.1 is selected from the group consisting of OH, (C.sub.1 -C.sub.12)alkyl, (C.sub.1 -C.sub.12)alkoxy, benzyloxy, phenyl, benzyl (C.sub.1 -C.sub.4)alkyl NZ.sub.1 Z.sub.2, and NZ.sub.1 Z.sub.2 ;R.sub.2 is selected from the group consisting of OH, SH, (C.sub.1 -C.sub.4)alkoxy, (C.sub.1 -C.sub.4)alkylthio, and NZ.sub.1 Z.sub.2 ;R.sub.3 is selected from the group consisting of H, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkylthio, (C.sub.1 -C.sub.4)alkoxy, phenyl, and benzyl;B is selected from the group consisting of phenyl; pyridyl; phenyl substituted by one or more groups selected from halo, (C.sub.1 -C.sub.6)alkyl, (C.sub.1 -C.sub.6)alkoxy, CF.sub.3, CH.sub.2 NZ.sub.1 Z.sub.2, and NZ.sub.1 Z.sub.2 wherein Z.sub.1 and Z.sub.2 are selected, independently of each other, from the group consisting of H, (C.sub.1 -C.sub.6)alkyl, formyl, and benzyl or --NZ.sub.1 Z.sub.
    Type: Grant
    Filed: July 12, 1994
    Date of Patent: November 21, 1995
    Assignee: Elf Sanofi
    Inventors: Andre Bachy, Laurent Fraisse, Peter Keane, Etienne Mendes, Jean-Claude Vernieres, Jacques Simiand
  • Patent number: 5360799
    Abstract: Compounds of formula ##STR1## in which R.sub.1 represents OH, (C.sub.1 -C.sub.12)alkyl, (C.sub.1 -C.sub.12)alkoxy, benzyloxy, benzyl, phenyl, (C.sub.1 -C.sub.4)alkylNZ.sub.1 Z.sub.2 or NZ.sub.1 Z.sub.2 ; R.sub.2 represents OH, SH, (C.sub.1 -C.sub.4)alkoxy, (C.sub.1 -C.sub.4)alkylthio or NZ.sub.1 Z.sub.2 ; R.sub.3 represents H, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkylthio, (C.sub.1 -C.sub.4)alkoxy, phenyl or benzyl; A represents N and R represents H or (C.sub.1 -C.sub.4)alkyl which can be substituted by phenyl or NZ.sub.1 Z.sub.2 ; B represents phenyl which is coupled to the pyridyl ring and is optionally substituted by one or more groups chosen from halo, (C.sub.1 -C.sub.6)alkyl, (C.sub.1 -C.sub.6)alkoxy, CF.sub.3, CH.sub.2 NZ.sub.1 Z.sub.2 or NZ.sub.1 Z.sub.2 ; and Z.sub.1 and Z.sub.2 represent, independently of each other, H, (C.sub.1 -C.sub.6) alkyl, formyl or benzyl, or they form with the nitrogen atom to which they are attached an optionally substituted saturated heterocycle and their salts.
    Type: Grant
    Filed: August 19, 1993
    Date of Patent: November 1, 1994
    Assignee: Elf Sanofi
    Inventors: Andre Bachy, Laurent Fraisse, Peter Keane, Etienne Mendes, Jean-Claude Vernieres, Jacques Simiand
  • Patent number: 4788188
    Abstract: The present invention relates to new quinolylglycinamide derivatives corresponding to the following general formula: ##STR1## The invention also relates to a process for preparing these compounds and their therapeutic application as a psychotropic agent.
    Type: Grant
    Filed: May 6, 1986
    Date of Patent: November 29, 1988
    Assignee: Sanofi (S.A.)
    Inventors: Jean-Claude Vernieres, Etienne Mendes, Michel Morre, Peter Keane, Jacques Simiand